X4 Pharmaceuticals (XFOR) Share-based Compensation Growth (3y) (2020 - 2025)
X4 Pharmaceuticals (XFOR) Share-based Compensation Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.91% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.95% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.93% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.55% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 30.98% |
| 10 | X4 Pharmaceuticals | 533.17 Mn | 338.08 Mn | 7.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.07% |
| Sep 30, 2025 | 31.15% |
| Jun 30, 2025 | -36.84% |
| Mar 31, 2025 | 251.02% |
| Dec 31, 2024 | 11.28% |
| Sep 30, 2024 | 6.28% |
| Jun 30, 2024 | -7.37% |
| Dec 31, 2023 | 22.01% |
| Sep 30, 2023 | -16.23% |
| Jun 30, 2023 | 77.33% |
| Mar 31, 2023 | 38.96% |
| Sep 30, 2022 | -62.26% |
| Jun 30, 2022 | 89.98% |
| Mar 31, 2022 | -64.22% |
| Dec 31, 2021 | 77.44% |
| Sep 30, 2021 | 12.46% |
| Jun 30, 2021 | 176.19% |
| Dec 31, 2020 | 131.18% |
| Sep 30, 2020 | 145.02% |
| Jun 30, 2020 | -76.33% |